Fermentas International

• Led a minority investment in 2007, helping to fund a state-of-the-art clean room manufacturing facility
• Recruited Ken Fong, Ph.D., founder of Summit portfolio company Clontech Laboratories, as advisor
• Helped strengthen the company’s infrastructure by building financial controls and improving reporting standards
• Assisted in the establishment of new sales offices in China and North America and helped acquire several distributors
• Provided strategic guidance focused on driving investments in new product development and sales force expansion through critical analysis
• Helped evaluate strategic interest from potential acquirers and select the eventual acquirer

Fermentas had become one of the largest privately held companies in the molecular biology industry, selling more than 1000 products to leading researchers around the world. In 2010, Fermentas was acquired by Thermo Fisher Scientific.

‍

‍

‍

_{The Portfolio Company Executive quoted herein did not receive compensation for any statements regarding Summit Partners. However, since Fermentas International is a former portfolio company of Summit, this individual did receive general compensation in connection with his employment by the company. In addition, this individual is not an investor in a Summit fund but may have conflicts arising from his past role with Fermentas International due to the company’s relationship with Summit.}